Daniel Mukasa holds a PhD in Applied Physics and Materials Science from Caltech and completed postdoctoral work at MIT on AI and drug discovery applications. He previously worked as an AI/ML intern at Merck on antibody therapeutic design, and is now founder and CEO of AbInitio Bio.
Intro paths
YC
Daniel went through Y Combinator (Spring 2026) — any YC alum in your network can reach them through the YC community.
→
In turn, Daniel can intro founders to AbInitio Bio's investors below.
AbInitio Bio's investors · 1
Co-founders
Nisha Gopal· Founder